Philip Morris
A Critical Study of Methods of Assessment of Effects of Low Doses
Fields
- Author
- Fournier, E.
- Area
- REIF,HELMUT/OFFICE
- Type
- SCRT, REPORT, SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Attachment
- 2501171179/2501171407
- Site
- E5
- Request
- Stmn/R2-038
- Named Person
- Ames, B.
- Avogadro
- Belle
- Delphi
- Fisher
- Holloman
- Knudson
- Krewski
- Moolgavkar
- Thomas, G.
- Valleron, A.J.
- Venzen
- Avogadro
- Master ID
- 2501171179/1407
Related Documents:- 2501171179-1183 Is the Concept of Linear Relationship Between Dose and Effect Still A Valid Model for Assessing Risk Related to Low Doses of Carcinogens?
- 2501171184-1186 the Causes and Prevention of Cancer
- 2501171187-1194 How Biologically Based Models May Help Extrapolating Cancer Risk to Low Doses
- 2501171214-1258 Do Rodent Studies Predict Human Cancers?
- 2501171259-1262 the Delaney Clause - Linchpin of the Environmental Policy Edifice
- 2501171263-1269 Toxic Policy at Dead End: the Case of Arsenic
- 2501171270-1286 the Asbestos Example
- 2501171287-1301 the Case of Chlorine and Derivated Products (Vcm)
- 2501171302-1316 the Ddt : Example
- 2501171317-1335 Test of the Linear - No Threshold Theory of Radiation Carcinogenesis
- 2501171336-1354 Bladder Cancer in Rats Fed Sodium Saccharin - Mechanistic Data and Their Application in Risk Analysis
- 2501171355-1384 Environmental Tobacco Smoke and Lung Cancer Approaches to Risk Management
- 2501171385-1389 Endeavouring New Shores in the Estimation and Assessment of the Cancer Risk by Environment Materials (Abstract)
- 2501171390-1404 Health Effects of Historical Exposures to Asbestos
- 2501171405-1407 Exposure - Response : Asbestos and Mesothelioma
- Author (Organization)
- Inbifo, Institut Fur Biologische Forschung
- Litigation
- Stmn/Produced
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- ret32e00
Document Images
A critical study of methods of assessment
of effects of low doses
Prof. Etienne Fournier

A critical study of methods of assessment of the effects of low doses
P. Etienne Fournier (1993)
This paper sets out to be a consideration of the positions taken by
experimental toxicologists and regulatory bodies for more than 40 years and
on their necessary confrontation with the facts from human observation
conducted by clinical physicians and, preferably, by clinical toxicologists.
One objective is apparent, in any case part of all the legislation - that of
suppressing - in theory completely (objective 0), in practice in such a way as
to become indiscernible, and at worst to reduce substantially - ailments
connected with the absorption of chemical products however absorbed and
the clinical course of cancer.
Let us admit that in the usual constitution of discussion panels, clinical
toxicologists (representing internal medicine or occupational medicine)
although the only qualified observers, are practically excluded from the
final report in favour of experimental toxicologists or analysts. This is not a
paradox, since each of their contributions stresses actual facts including a
strong probability of correlation between a known exposure and the too
premature, too frequent and excessively atypical incidence of certain
cancers.
From these comes the set of agreed procedures which are transcribed and
quantified to achieve national and international regulation.
Calculations in this matter are those of epidemiologists and biostatisticians
and evaluation of doses those of analysts:
A first logical, quasi-mathematical, relationship will be established: For
one exposure to x, ppm in the air or for oral absorption of x2 mglKg/day, n
cancers appear (in the context of the study: target population, - exposure
time, time before appearance, & -).

A second relationship, no less classical, normally follows.
It is defined in accordance with methods which avoid the essential bias of
the number of these cancers observed in a reference population suffering no
exposure to the target chemical hazard. In general, it results in a mortality
coefficient implying excess mortality for a defined exposure.
From the moment when the set of interpretations begins, the most frequent
being a major increase through a purely formal movement to sufficiently
large numbers:
For example, if X has observed two fatal cancers in the target population
and only one in the control population, Y can say that the SMR ratio is
200%. Whilst recognizing immediately that this simple outline is not only
unacceptable but is far from representing the reality of the cancerous
condition.
a) Most common hormone-sensitive cancers currently treated are cured or
benefit from a prolonged remission. Indeed the morbidity of cancer is
exceptionally well-documented.
b) The relative importance of cancers subject to hormonal influence has not
ceased to grow and this group does not always have an obvious connection
with toxic impregnation, with the exception of thyroid cancers, although an
associated effect should be observed.
c) Conversely, cancers appear in subjects treated and cured by the use of
radiation or drugs primarily acting on DNA.
d) Other pathological phenomena certainly recognized apart from the
transmission of transplacental products, individual predispositions in
individuals who are carriers of inherited cancers, identify genetic criteria
in families where the preponderance of cancer amongst the causes of
morbidity is important. This notion is particularly useful in the study of u~i
a
childhood cancers. ~
~
~
~
2

This is found in an exaggerated manner in subjects who are carriers of
inherited abnormalities relating to the DNA and its repair, and who
present a greater prevalence of cancers of the skin or blood (leukaemias and
lymphomas).
There are too few such families to identify from them response criteria to
chemical products. And caffeine, the classical inhibitor of DNA repair, has
no demonstrated role in experimental carcinogenesis.
e) The most common cancers of chemical origin are cancers of the lung due
to chronic addiction to smoking with constant exposure to several grams of
carcinogenic substances over the bronchial mucous membrane,
photosensitive skin cancers susceptible to activation by chemical products
and of the bladder after excessively prolonged impregnation (aromatic
amines).
In all three cases cellular exposure is massive and prolonged.
Asbestos cancers in the form of mesothelioma are comparable with them
because of a considerable accumulation of asbestos fibrilla irreversibly
accumulated in the serous membrane.
In fact, human cancers due to chemical products (the "may cause human
cancer" category) appear after long periods of close and significant contact
between a cellular type and the product itself or its metabolites.
The "one hit - one cancer" hypothesis should therefore be questioned. This
slogan is suspect because it is a slogan. It cannot simply be accepted.
Clinicians have never taken steps to observe a cancer occurring after one
single minimal contact, which certainly does not mean that this method of
occurrence cannot be suggested as one possible hypothesis. Each individual
is free to express his views. But this first attitude, an extreme one, is also
one which prevents all subsequent discussion, since no individual has been
totally protected from the sun or fumes. In advance we are all cancerous -
which will perhaps be confirmed but in different ways.
3

A better quantitative approach to the initial mutation phenomenon might be
assessment involving tests on procarocytes of the minimum concentration
effective. In the usual literature, the biologist looks for an obvious effect
which he calls positive and which he contrasts with doubtful or negative
results. It would be interesting to test the molecules by specifying the
threshold-concentration from observation of a rise in mutations compared
with the spontaneous mutations of the original preparation.
Even if we do not know the cause of spontaneous mutations we may assume
that they relate to a random process on the scale of a micro-organism which
becomes a measurable constant for the population, and the deviation from
the constant may be a good experimental index for the effect of low dose-
concentrations (less than 1-9M). The same reasoning is proposed for organs
and their cellular population.
Proposed extrapolations
a) anirnal references
Since no cancer due to a chemical product can have been observed in man
in the purest imaginable environmental conditions, the logical stance
would be to take experimental data supported by control animals reared
under rigorous conditions: water, food, air, accommodation and free of
viral immunological reactions. Even if all is not yet perfect in the field of
good laboratory practice, experimenters are nearing perfection. They also
note.that the spontaneous mortality, apparently inescapable, of such
animals is largely of cancerous origin, and that the date of appearance of
cancers depends on the species and the breed.
N.B. 1 Epidemiologists, for their part, give us to understand that the prevalence of human
cancers is a function of age:lcA5, but this proposition has only modest consequences if the
average lifespan varies little from one population to another. Thus the variation from 70 to
75 years (considerable average variation) only increases the probability caused by 41%.
4 2501171199

N.B.2 An extrapolation by linear or even semi-logarithmic function towards doses - or
concentrations - considerably lower than those for which cancers have been observed in
man or animals, leads to non observable rates of effect still comparable with the initial
doses, generally very high (n mg/Kg/day).
Over some forty years an abstract approach has developed based on
hypotheses which at first were the interpretation of extremely simplistic
elementary principles but which have evolved through the introduction of
the biological knowledge accumulated during recent years and the biology
of DNA.
Let us briefly recall them:
First hypothesis: only one particular shock - production of a single radical
OH* - causes DNA to explode (cellular death) or deforms it sufficiently for
the cell to become uncontrollable (one hit one cancer).
Apart from its fundamental drawbacks, the hypothesis ill applies to the
absorption of chemical substances or to the effect of their metabolites.
Avogadro's constant 6.02 1023 implies that the nanogram supports an
average of 3 10 12 reactive poles. This is considerably more than can be
supported by an organism if each cell absorbing a single reactive molecule
were to become cancerous.
Second hypothesis: It refers to the most generally accepted knowledge of
cancerisation, the current theory 'making to succeed' an initial stage
which remains latent in successive phases of advancement. If the same
molecule is initiator and promoter, the hypothesis of a multiple stage
reaction is acceptable. Unfortunately our knowledge about promoters is still
very hazy compared with what we know about initiators and complete
carcinogens. If we admit that a very large number of molecules such as
some phenols are promoters and that the human being always carries
them, we are brought back to the previous stage.
5

For initiators the current theory would be that of incomplete repairs leaving
adduct-mutations in place, becoming more and more numerous.
For promoters a consensus without formal reason agrees somewhat
shamefacedly to consider that they only act above a certain threshold.
Third hypothesis: This results from knowledge of anticancerous genes -
emerogenes. These can as well be stimulated by both chemical products as
pro-oncogenes. Similarly, damaged DNA excision-repair phenomena unite
to prevent the appearance of immortal cells with carcinogenic potential.
The theory seeks a differential function between the initiator effect and the
repairer effect.
Fourth hypothesis: Coming finally to the in situ control of formed cancer
and its own evolution by metastases, attacks and phases of stabilization.
The simple theory holds that once formed, the initiated and promoted cell
divides in an inescapable way. In this case, whatever the duration of a
pathological division, the carrier of the cancerous mass should die within a
few days or months, which is effectively observed in acute forms. The actual
phenomenon becomes at least doubly random - uncertainty about the
progress and uncertainty about regression - in so far as we are incapable of
gauging the different factors and measuring the various cytokines which
regulate the complete process.
Mathematical analysis of sequential and contradictory cellular phenomena
calls on models of physio-pathological regulation. In respect of
mathematical carcinogenesis, we are unfortunately at the point where the
ancient Egyptian surveyors of a random expanse - the silt of the Nile - were,
before fundamental data about plane geometry. But additional data is
gradually appearing. Evaluation of resistance to a cancer has barely begun.
For we already know that not all asbestos workers die of mesothelioma even
if exposed to the maximum amount of dust.
25aiiil20i
6

On a simpler mode, not all the bacteria of the Ames system mutate when
they divide in a milieu containing a reference carcinogen, but it is clear that
the random nature of the mutation is located at a level other than that of the
non exposed population. The deregulation is explained by a coefficient of
mutagenesis:
It is in homologous terms that the coefficients of morbidity (rarely
recognized) and mortality (which are only valid for cancers which are often
fatal) appear. Uncertainty increases in the proximity of the coefficient 1 in
as much as the first serious observation was that of the "healthy worker
effect" which brings the coefficient to 0.8 during adult life.
Hence the extraordinary confusion of demands for nil risk, faced by
biologists and doctors who admit that this notion is strictly speaking
unrealistic (Krewoki et al 1984), which is not to say that to propose and
tolerate an added acceptable risk (between 10-5 and 10-8) makes more sense:
10'6 x 70 years: about 6 hours in terms of life expectancy.
The biologist accustomed to margins of error otherwise large has a poor
grasp of the practical value of attitudes, which may be compared to a
proposition of Pure Behavioral Act: Art. 1 "the designated population
should live without sin". Should the risk of sinning be agreed to be 10-5 or
10-8?
Should attempts at evaluating a carcinogenic effect be similarly rejected
wholesale? The answer is certainly no, provided the limits of models are
known.
* N.B. I would especially like to thank Professors A.J. Valleron and G. Thomas, who
described to me the methods used and the limits of use.
a) The model with threshold (tolerance model) assumes that a subject
exposed to a dose (cumulative) of a carcinogen will develop a cancerous
2501171202
7

tumour if the dose exceeds a threshold called a tolerance. Various
approaches are suggested (see Appendix).
These models are only valid for binary situations excluding all interference
from other factors, eliminating the time factor to the advantage of the single
cumulative dose. Elemental toxicology, throughout life, permits these
calculations.
These models are however little used, for it is rare that human observations
concern more than three situations: A lot, a little, or no chemical product.
Experiments on animals rarely involve more than three to four doses: one
close to the maximum dose more or less well tolerated (in the general
sense) by the animal; another fairly low dose is selected in the reasonable
expectation that nothing will be observed; and one or two intermediate doses
which are the only ones genuinely compatible with a sub-normal life
expectancy. In these conditions it is difficult to draw up a graph with a
single point - or two - and the regulations most frequently allow for the
lowest dose which showed no effect (NOEL).
Models allowing for the effect of time
Time is a fundamental variable of carcinogenesis but its introduction
necessitates a biological unity such as average life span or the extreme life
expectancy of the species or ethnic group, or that of the appearance of
perceptible phenomena of which cancers form a part.
There is no consensus about the mechanism of the increase in the
prevalence of cancer according to age (accumulation of errors, progressive
chromosomal abnormality, perigenic abnormality of the histones,
epigenetic abnormalities of cellular regulators (hormones, adenylcyclases,
calcic mediators etc.), but an experimental gain is confirmed by monitoring
animals throughout their lives.
Little by little the notion is taking hold that in certain mammals the
prevalence of cancerous mortality becomes preponderant in excess of 70%.
2501171203
g

In man the situation is evolving in the same direction although the part
played by degenerative causes with cellular death remains high.
If the average life span reaches 80 years cancerous morbidity should
become considerable.
N.B. This discussion is different from that about the sensitivity of elderly subjects to
exposure to carcinogens.
Models using time refer to empirical models called log-linear, of the type
T (probability - distribution according to observation)
T=exp( B1 Z + yW )
p. vector p. vector actual random variable
of parameters of functions
of a single dose
or of regression (Lox)
y (t:d) = yo W exp (6'Z(t)))
and models based on biological hypotheses : multi-hits, multi-stage. These
already old models like those of Fisher and Holloman (1951) have had the
merit of taking parallel events into account (more than six cells
transformed together - abandoned- ) or more DNA disorders (6-7 successive
mutations on the same cell). The latter argument was essential to explain
why the incidence of many human cancers would grow with age to the
power of 5 or 6.
We acknowledge that currently the appearance of a cancer supposes at least
two, and probably fewer than seven predisposing factors affecting one cell.
The model derived from the work of Moolgavkar, Venzon and Knudson
( 1981) results in an outline consisting of normal and intermediate cells and
those proliferating out of control, capable of reproducing themselves as they
are, of leading to the later stages, or dying.
Recent models associated with validated experimental or epidemiological
data, studies of absorption or metabolisms, encompass usable results for
9
